PRSO insider grant: 25,000 options vest monthly over 3 years
Rhea-AI Filing Summary
Peraso Inc. insider grant: Ronald Glibbery, who is listed as both Chief Executive Officer and a director of Peraso Inc. (PRSO), was granted a stock option on 08/07/2025 to buy 25,000 shares of common stock at an exercise price of $0.8399 per share. The option vests in 36 equal monthly installments (1/36th on each monthly anniversary beginning August 7, 2025) and the reported expiration date is August 7, 2035. The filing reports the options as directly beneficially owned by Mr. Glibbery and shows 25,000 derivative securities of this class following the transaction. No other non-derivative transactions are reported in this Form 4.
Positive
- CEO received 25,000 stock options at an exercise price of $0.8399, aligning management incentives with shareholders
- Vesting schedule is clear: 1/36th vests monthly beginning 08/07/2025, encouraging retention over three years
Negative
- None.
Insights
TL;DR: Routine executive equity grant aligning CEO compensation with long-term share performance; appears non-disruptive.
The Form 4 discloses a standard option award to the CEO and director that vests monthly over three years and expires in 2035. From a governance perspective, staggered monthly vesting encourages retention and ongoing alignment with shareholder value without an immediate dilutive impact beyond the disclosed 25,000-option grant. The report indicates direct ownership of the derivative security class and does not disclose other transactions or offsets that would materially change control or capital structure.
TL;DR: Compensation grant is modest in size and structured for retention; impact on financials and dilution is likely limited.
This option award carries an exercise price of $0.8399 and vests 1/36th monthly beginning on the grant date, implying full vesting after three years and an expiration date a decade after grant. The disclosure shows 25,000 options outstanding to the reporting person in this derivative class post-transaction. There is no cash payment for the grant indicated in the Form 4 and no concurrent disposals or exercises reported that would alter immediate share count.